ICHR
Overvalued by 72.2% based on the discounted cash flow analysis.
Market cap | $578.42 Million |
---|---|
Enterprise Value | $565.77 Million |
Dividend Yield | $- (-) |
Earnings per Share | $-0.64 |
Beta | 1.75 |
Outstanding Shares | 34,179,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -27.84 |
---|---|
PEG | -33.13 |
Price to Sales | 0.6 |
Price to Book Ratio | 0.8 |
Enterprise Value to Revenue | 0.61 |
Enterprise Value to EBIT | -34.11 |
Enterprise Value to Net Income | -28 |
Total Debt to Enterprise | 0.14 |
Debt to Equity | 0.11 |
No data
No data